Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.

Quotes for Scandion Oncology

Right Now

+/-
-0.78
%
-6,62%
Latest
11
High
11.96
Low
10.74
Volume
46 854
Turnover (SEK)
527 017
Value (MSEK)
209,6

Board

CEO

  • Nils Brünner

Chairman Of The Board

  • Peter Høngaard

Board

  • Carl Borrebäck
  • Christian Vinding Thomsen
  • Jørgen Bardenfleth
  • Thomas Feldthus

Videos

Key Numbers

*Compiled data from Millistream